Healthcare · head to head
Gleamer vs Rx30

Gleamer
Healthcare
CE marked and FDA cleared imaging AI suite for bone trauma and chest, now owned by RadNet
- From
- On request
- Rated
- -

Rx30
Healthcare
Long-established pharmacy management system for independents and small chains
- From
- On request
- Rated
- -
The short version
- Each has a real cost: Gleamer radNet, an imaging provider that competes with many independent Gleamer customers, now owns the company and also owns the competing DeepHealth AI portfolio, so roadmap and pricing priorities are an open question for non-RadNet buyers.; Rx30 shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally
- They diverge on capability: Gleamer covers BoneView, Rx30 covers Prescription processing.
- Prices and features above were last checked on 1 September 2026.
Where they differ
Only the attributes on which Gleamer and Rx30 actually diverge.
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Gleamer
- BoneView
- ChestView
- BoneAge
- BoneMetrics
- LungCT and BoneCT
- BreastView
- Pixyl.Neuro
- Gleamer Copilot
Only in Rx30
- Prescription processing
- Claims adjudication
- Inventory and purchasing
- Point of sale
- Delivery management
- Clinical documentation
What people use each for
The jobs each tool is most often brought in to do.
Gleamer
- An emergency department where junior doctors read plain films before radiology review and missed fractures are a recurring incident themenot Rx30
- An urgent care network standardising musculoskeletal reading quality across sites with variable radiology covernot Rx30
- A paediatric service automating bone age assessment to remove a slow manual atlas comparisonnot Rx30
- An orthopaedic service that needs automated limb alignment and measurement before surgical planning rather than manual measurement on the workstationnot Rx30
Rx30
- Independent pharmacies and small chains wanting a mature, widely-supported systemnot Gleamer
- Operations relying on a broad set of wholesaler and PBM interfacesnot Gleamer
- Pharmacies with significant front-end retail alongside dispensingnot Gleamer
- Multi-store independents needing consistency across locationsnot Gleamer
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Gleamer
- RadNet, an imaging provider that competes with many independent Gleamer customers, now owns the company and also owns the competing DeepHealth AI portfolio, so roadmap and pricing priorities are an open question for non-RadNet buyers.
- The measured benefit is largest for less experienced readers, so a specialist musculoskeletal service will see far less improvement than the published reader studies suggest.
- Cleared indications differ per module and per market, and the FDA cleared set is narrower than the CE marked European set, so an American buyer cannot rely on European reference sites.
- Each additional module adds alert volume into the same worklist, and departments running several Gleamer algorithms report needing local threshold tuning to keep radiologist trust.
- Pricing is per exam and not published, which makes budgeting difficult for an emergency department whose plain film volume swings seasonally.
Rx30
- Shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally
- The interface shows its age against newer entrants, and this is the most common objection in demonstrations
- Pricing is not published, and total cost including hardware and interfaces needs to be requested explicitly
- Windows-centric, with a cloud story less developed than newer competitors
- US-only, tied to US insurance and regulatory requirements
Pricing, plan by plan
Gleamer
On request- Gleamer Copilot$undefined/year
- Priced per exam analysed or as an annual volume subscription
- Modules licensed individually or bundled as Copilot
- Cleared and CE marked indication differs per module and per market
Rx30
On request- Rx30$undefined/month
- Prescription processing
- Claims adjudication
- Inventory
Which should you pick?
Choose Gleamer if
- You need boneview.
- You work on Web, Cloud, On-premise.
- You also want chestview.
Choose Rx30 if
- You need prescription processing.
- You work on Windows, Web.
- You also want claims adjudication.
Questions people ask
- Is Gleamer or Rx30 better?
- Neither clearly leads. Gleamer starts at On request and Rx30 at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Gleamer or Rx30?
- Gleamer starts at On request and Rx30 at On request.
- Does Gleamer or Rx30 run on more platforms?
- Gleamer runs on Web, Cloud, On-premise. Rx30 runs on Windows, Web.
- What is Gleamer best used for?
- Gleamer is most often used for an emergency department where junior doctors read plain films before radiology review and missed fractures are a recurring incident theme, an urgent care network standardising musculoskeletal reading quality across sites with variable radiology cover, a paediatric service automating bone age assessment to remove a slow manual atlas comparison, an orthopaedic service that needs automated limb alignment and measurement before surgical planning rather than manual measurement on the workstation. Of those, an emergency department where junior doctors read plain films before radiology review and missed fractures are a recurring incident theme and an urgent care network standardising musculoskeletal reading quality across sites with variable radiology cover are not what Rx30 is typically brought in for.
- What can Gleamer do that Rx30 cannot?
- Gleamer covers BoneView, ChestView, BoneAge, BoneMetrics. Rx30 covers Prescription processing, Claims adjudication, Inventory and purchasing, Point of sale.
Answered from the vendors’ own pages
Gleamer: Who owns Gleamer?
RadNet agreed to acquire Gleamer in February 2026 for around two hundred and fifteen million euros upfront. RadNet also owns DeepHealth, a competing AI portfolio.
Rx30: Is Rx30 the same company as PioneerRx?
Both are owned by RedSail Technologies. They are sold as separate products to overlapping markets, but roadmap decisions sit with one company, which is worth knowing before treating them as independent options.
Gleamer: Is BoneView FDA cleared?
Yes, BoneView holds 510(k) clearance including for paediatric fracture detection, but the cleared finding set is narrower than the CE marked indication in Europe.
Rx30: What does it cost?
Not published. Request the total including hardware, interfaces and training rather than the monthly software fee.
Gleamer: What does the evidence actually show?
Multi-reader studies reported improved reader sensitivity for fracture detection and fewer false negatives, with the gain concentrated among less experienced readers in emergency settings.
Rx30: Why do pharmacies stay on it?
Installed base maturity. The interfaces to wholesalers, PBMs and hardware are long established, and those are the things that quietly stop a pharmacy working when they break.
Gleamer: Can I buy just BoneView?
Yes, modules are licensed individually, though the commercial pitch is now the Copilot bundle across modalities.
Rx30: How does it compare to PioneerRx?
PioneerRx is more aggressively developed around clinical services. Rx30 has the larger legacy base and broader front-end retail heritage. Same owner, different emphasis.
Rx30: Is it suitable for a small chain?
Yes, and that is one of its stronger cases. Multi-store consistency is better handled here than by the systems aimed purely at single independents.
Related pages
Other head to heads
- Gleamer vs Annalise.ai
- Gleamer vs Sectra
- Gleamer vs Rad AI
- Gleamer vs Lunit
- Gleamer vs Techcyte
- Gleamer vs Philips IntelliSpace PACS
- Gleamer vs Visage Imaging
- Gleamer vs Paige
- Gleamer vs Therapixel
- Gleamer vs Fujifilm Synapse
- Gleamer vs Ibex Medical Analytics
- Gleamer vs Hinge Health
- Gleamer vs Meru Health
- Gleamer vs NextGen Healthcare
- Gleamer vs Nookal
- Gleamer vs Open Dental
- Gleamer vs Oracle Clinical One
- Gleamer vs Phreesia
- Gleamer vs Liberty Software
- Gleamer vs BestRx
- Gleamer vs Epic Systems
- Gleamer vs Cerner
- Gleamer vs Dentrix
- Gleamer vs Zocdoc
- Gleamer vs eClinicalWorks
- Gleamer vs GoodRx
- Gleamer vs Ro
- Gleamer vs SilverCloud by Amwell
- Gleamer vs OpenClinica
- Gleamer vs Bahmni
- Gleamer vs Beckman Coulter DxONE
- Gleamer vs Carestream Dental
- Gleamer vs ChiroTouch
- Gleamer vs Cerner PowerChart
- Gleamer vs Cerner PowerWorks
- Rx30 vs Annalise.ai
- Rx30 vs Sectra
- Rx30 vs Rad AI
- Rx30 vs Lunit
- Rx30 vs Techcyte
- Rx30 vs Philips IntelliSpace PACS
- Rx30 vs Visage Imaging
- Rx30 vs Paige
- Rx30 vs Therapixel
- Rx30 vs Fujifilm Synapse
- Rx30 vs Ibex Medical Analytics
- Rx30 vs Hinge Health
- Rx30 vs Meru Health
- Rx30 vs NextGen Healthcare
- Rx30 vs Nookal
- Rx30 vs Open Dental
- Rx30 vs Oracle Clinical One
- Rx30 vs Phreesia
- Rx30 vs Liberty Software
- Rx30 vs BestRx
- Rx30 vs Epic Systems
- Rx30 vs Cerner
- Rx30 vs Dentrix
- Rx30 vs Zocdoc
- Rx30 vs eClinicalWorks
- Rx30 vs GoodRx
- Rx30 vs Ro
- Rx30 vs SilverCloud by Amwell
- Rx30 vs OpenClinica
- Rx30 vs Bahmni
- Rx30 vs Beckman Coulter DxONE
- Rx30 vs Carestream Dental
- Rx30 vs ChiroTouch
- Rx30 vs Cerner PowerChart
- Rx30 vs Cerner PowerWorks
